Nucleic Acids Research, 1984, Vol. 12, No. 10 4063-4069
© 1984
MOLECULAR BIOLOGY |
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
Sclavo Research Centre Via Fiorentina, 1, 53100 Siena, Italy
*To whom correspondence should be sent
Received April 13, 1984. Accepted May 2, 1984.
The amino-acid sequences of two diphtheria toxin-related, non-toxic proteins, CRM45 and CRM197, were deduced from the complete sequence of their genes: tox 45 and tox 197. CRM45 lacks the last 149 C-terminal amino-acid residues, but is otherwise identical to diphtheria toxin: a single C
T transition introduces an "ochre" (TAA) termination signal in tox 45, after the codon for threonine-386. A single G
A transition was also found in tox 197, leading to the substitution of glycine-52, present in the wild-type toxin, with glutamic acid in CRM197. This aminoacid change is responsible for the loss of the NAD:EF2 ADP-riboayltransferase activity in CRM197, due moat probably to an alteration of the NAD+ binding site.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Stickings, M. Peyre, L. Coombes, S. Muller, R. Rappuoli, G. Del Giudice, C. D. Partidos, and D. Sesardic Transcutaneous Immunization with Cross-Reacting Material CRM197 of Diphtheria Toxin Boosts Functional Antibody Levels in Mice Primed Parenterally with Adsorbed Diphtheria Toxoid Vaccine Infect. Immun., April 1, 2008; 76(4): 1766 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kageyama, M. Ohishi, S. Miyamoto, H. Mizushima, R. Iwamoto, and E. Mekada Diphtheria Toxin Mutant CRM197 Possesses Weak EF2-ADP-ribosyl Activity that Potentiates its Anti-tumorigenic Activity J. Biochem., July 1, 2007; 142(1): 95 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Torosantucci, C. Bromuro, P. Chiani, F. De Bernardis, F. Berti, C. Galli, F. Norelli, C. Bellucci, L. Polonelli, P. Costantino, et al. A novel glyco-conjugate vaccine against fungal pathogens J. Exp. Med., September 6, 2005; 202(5): 597 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baraldo, E. Mori, A. Bartoloni, F. Norelli, G. Grandi, R. Rappuoli, O. Finco, and G. Del Giudice Combined Conjugate Vaccines: Enhanced Immunogenicity with the N19 Polyepitope as a Carrier Protein Infect. Immun., September 1, 2005; 73(9): 5835 - 5841. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Berti, P. Costantino, M. Fragai, and C. Luchinat Water Accessibility, Aggregation, and Motional Features of Polysaccharide-Protein Conjugate Vaccines Biophys. J., January 1, 2004; 86(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Miyaji, R. P. Mazzantini, W. O. Dias, A. L. T. O. Nascimento, R. Marcovistz, D. S. Matos, I. Raw, N. Winter, B. Gicquel, R. Rappuoli, et al. Induction of Neutralizing Antibodies against Diphtheria Toxin by Priming with Recombinant Mycobacterium bovis BCG Expressing CRM197, a Mutant Diphtheria Toxin Infect. Immun., February 1, 2001; 69(2): 869 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Orr, J. E. Galen, and M. M. Levine Expression and Immunogenicity of a Mutant Diphtheria Toxin Molecule, CRM197, and Its Fragments in Salmonella typhi Vaccine Strain CVD 908-htrA Infect. Immun., August 1, 1999; 67(8): 4290 - 4294. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Ayre, U. Kohler, H. M. Goodman, and J. Haseloff Design of highly specific cytotoxins by using trans-splicing ribozymes PNAS, March 30, 1999; 96(7): 3507 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thompson, H. Hu, J. Scharff, and D. M. Neville Jr. An Anti-CD3 Single-chain Immunotoxin with a Truncated Diphtheria Toxin Avoids Inhibition by Pre-existing Antibodies in Human Blood J. Biol. Chem., November 24, 1995; 270(47): 28037 - 28041. [Abstract] [Full Text] [PDF] |
||||





